March 24th 2023
In a recent study, women with symptomatic uterine fibroids saw reduced symptom burden and improved quality of life after 24 weeks of treatment through relugolix combination therapy.
A call to action for treating uterine fibroidsMay 17th 2022
A call to action in the journal Reproductive Sciences hopes to empower health care providers to optimize their quality of care for women with uterine fibroids by relying on the best available evidence and best patient-centered practices.
UAE vs MRI-guided HIFU for fibroid reduction ratesApril 7th 2022
Among minimally invasive treatments for uterine fibroids, uterine artery embolization (UAE) produces greater fibroid shrinkage and more complications than MRI-guided HIFU (MRIgHIFU), according to a study in BMC Women’s Health.
Uterine fibroids and risk of depression, anxiety, and self-directed violenceMarch 29th 2022
Women with uterine fibroids (UF) experience higher rates of depression, anxiety, and self-directed violence, especially those with pain or who have had a hysterectomy, according to a study published in the Journal of Epidemiology and Community Health.
Ultrasound for uterine fibroidsMarch 17th 2022
“Although traditional surgical treatments can resolve the clinical symptoms, they have many disadvantages, such as relatively large trauma, high chances of postoperative complications and long operation time,” wrote the authors of the review in the International Journal of Hyperthermia.
Myomectomy surgical choice considerationsMarch 17th 2022
A recent study compared the effectiveness of open, laparoscopic, and robotic surgery in terms of outcomes and post-operative pregnancy success, and found that minimally invasive methods were best, according to a study published in JBRA Assisted Reproduction.
Uterine artery embolization or myomectomy for uterine fibroidsFebruary 11th 2022
A 4-year follow-up of a randomized control study comparing uterine artery embolization (UAE) to myomectomy for treating women with uterine fibroids has concluded that myomectomy achieves greater improvement in quality of life.
Analysis shows steep costs for uterine fibroid and heavy menstrual bleeding treatmentFebruary 11th 2022
Uterine fibroids (UF) with heavy menstrual bleeding (HMB) pose a significant economic burden—mostly due to surgical and procedural costs and treatment, according to a claims analysis in the Journal of Women’s Health.
A look at the current state of uterine fibroid careFebruary 10th 2022
“Over 70% of women are estimated to develop uterine fibroids by age 50,” said senior author Irene Aninye, PhD, chief science officer for the Society for Women’s Health Research (SWHR) in Washington, D.C. “Fibroids are a complex condition that can range from being asymptomatic to having deleterious effects on a woman’s health and quality of life.”
Relugolix for treating uterine fibroidsJanuary 19th 2022
A phase 2, multicenter study has found relugolix (Myfembree; Myovant Sciences) significantly decreases menstrual blood loss in women with uterine leiomyomas and is mostly well tolerated. Relugolix is a small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
Disparities for Black women with uterine fibroidsDecember 17th 2021
Many of the glaring disparities that exist in care for the 26 million women in the United States who suffer from uterine fibroids, which disproportionately affects up to 80% of Black women, are being aggressively addressed though a new multifaceted campaign called UNmuting Fibroids.
The relationship between uterine fibroids and infertilityNovember 12th 2021
Due to uterine fibroids being a potential cause of infertility, treatment options like myomectomy should be discussed individually with the patient, according to an article published in Diagnostics that evaluated the relationship.
PFAS in drinking water and its impact on the female reproductive systemSeptember 7th 2021
A Swedish cohort study in the journal Environment International has found that women of fertile age who were exposed to high levels of perfluorinated substances (PFAS) in drinking water were significantly more likely to subsequently have a diagnosis of polycystic ovarian syndrome (PCOS) and possibly uterine leiomyoma (or uterine fibroids [UFs]), but not endometriosis.
The impact of nutrition on gynecological diseasesAugust 20th 2021
Several dietary supplements and nutrients potentially provide benefits in preventing and treating common gynecological diseases like uterine fibroids (UFs), endometriosis, polycystic ovarian syndrome (PCOS), infertility, menstrual disorders and vaginal infections, according to an article in the journal Nutrients.
Emergency department visits increase for fibroids, while hospital admissions decreaseAugust 12th 2021
Emergency department (ED) visits in women affected by leiomyomas, or uterine fibroids (UFs), are increasing, but hospital admissions for this patient population are decreasing, according to a study published in the journal Obstetrics & Gynecology.
Does bacterial vaginosis increase risk of developing uterine fibroids?June 24th 2021
No evidence exists that bacterial vaginosis (BV)-associated bacteria increases the risk of developing uterine fibroids (UFs) or the number of UFs, according to a nested case-control study in the journal Sexually Transmitted Diseases.
Ethnoracial factors in uterine fibroid careJune 8th 2021
A qualitative study in the Journal of Racial and Ethnic Health Disparities has concluded that ethnic and racial considerations can have significant impact on patient experience of uterine fibroid (UF) diagnosis and management.